Bloomberg Report: HHS Recommends Marijuana Move To Schedule III

Bloomberg News is reporting that the Department of Health and Human Services has recommended to the U.S. Drug Enforcement Administration, to whom power is delegated under the Controlled Substances Act by the Attorney General, that cannabis be re-scheduled to Schedule III of the Controlled Substances Act. The recommendation is apparently based on a scientific and medical review by the Food and Drug Administration ordered last year by President Biden. If true, the FDA's new findings would reverse the agency's determination as recently as 2016 that cannabis should remain a Schedule I Controlled Substance when a rescheduling petition was denied. Schedule I controlled substances have a high potential for abuse with no accepted medical use in the US and a lack of accepted safety for use under medical supervision. As we all know, that is an inappropriate classification for cannabis.